Arcellx, Inc. (ACLX) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ACLX Revenue Growth
ACLX Revenue Analysis (2018–2025)
As of May 8, 2026, Arcellx, Inc. (ACLX) generated trailing twelve-month (TTM) revenue of $22.3 million, reflecting significant decline in growth of -89.2% year-over-year. The most recent quarter (Q4 2025) recorded $1.7 million in revenue, down 66.6% sequentially.
Looking at the longer-term picture, ACLX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $110.3 million in 2023.
When compared to Healthcare sector peers including LEGN (+64.2% YoY), KYMR (-12.6% YoY), and CRSP (-88.9% YoY), ACLX has underperformed the peer group in terms of revenue growth. Compare ACLX vs LEGN →
ACLX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ACLXCurrent | $22M | -89.2% | - | -1135.6% | |
 LEGN | $1.0B | +64.2% | +68.9% | -13.3% | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 CRSP | $4M | -88.9% | +37.3% | -16191.4% | |
 FATE | $7M | -51.2% | -26.7% | -2222.4% |
ACLX Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $22.3M | -79.4% | $15.6M | 70.0% | $-253,083,000 | -1135.6% |
| 2024 | $107.9M | -2.2% | $102.7M | 95.2% | $-137,571,000 | -127.5% |
| 2023 | $110.3M | - | $110.3M | 100.0% | $-89,880,000 | -81.5% |
| 2022 | $0 | - | $-2,224,000 | - | $-191,259,000 | - |
| 2021 | $0 | - | $0 | - | $-65,018,000 | - |
| 2020 | $0 | - | $0 | - | $-32,095,999 | - |
| 2019 | $0 | - | $-326,000 | - | $-17,974,000 | - |
| 2018 | $0 | - | $0 | - | $-8,309,000 | - |
See ACLX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACLX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACLX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonACLX — Frequently Asked Questions
Quick answers to the most common questions about buying ACLX stock.
Is ACLX's revenue growth accelerating or slowing?
ACLX revenue declined -89.2% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $22M. This reverses the prior growth trend.
What is ACLX's long-term revenue growth rate?
Arcellx, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -89.2% is below this long-term average.
How is ACLX's revenue distributed by segment?
ACLX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.